143 related articles for article (PubMed ID: 24576738)
1. Have we overestimated the risk of lymphoma associated with thiopurine treatment for ulcerative colitis?
Kumar AR; Dudnick RS
Gastroenterology; 2014 Apr; 146(4):1131. PubMed ID: 24576738
[No Abstract] [Full Text] [Related]
2. Reply: To PMID 23891975.
Abbas AM; Khan N; Bazzano LA
Gastroenterology; 2014 Apr; 146(4):1131-3. PubMed ID: 24576737
[No Abstract] [Full Text] [Related]
3. Lymphoma: the bête noire of the long-term use of thiopurines in adult and elderly patients with inflammatory bowel disease.
Beaugerie L
Gastroenterology; 2013 Nov; 145(5):927-30. PubMed ID: 24070724
[No Abstract] [Full Text] [Related]
4. Risk of lymphoma in patients with ulcerative colitis treated with thiopurines: a nationwide retrospective cohort study.
Khan N; Abbas AM; Lichtenstein GR; Loftus EV; Bazzano LA
Gastroenterology; 2013 Nov; 145(5):1007-1015.e3. PubMed ID: 23891975
[TBL] [Abstract][Full Text] [Related]
5. A Case of Thiopurine-Induced Acute Myocarditis in a Patient with Ulcerative Colitis.
Latushko A; Ghazi LJ
Dig Dis Sci; 2016 Dec; 61(12):3633-3634. PubMed ID: 27766449
[No Abstract] [Full Text] [Related]
6. Poor response to thiopurine in inflammatory bowel disease: how to overcome therapeutic resistance?
Chouchana L; Roche D; Jian R; Beaune P; Loriot MA
Clin Chem; 2013 Jul; 59(7):1023-6. PubMed ID: 23813427
[No Abstract] [Full Text] [Related]
7. Dangers of immunosuppressive drugs in ulcerative colitis.
Br Med J; 1966 Aug; 2(5509):361-2. PubMed ID: 5920661
[No Abstract] [Full Text] [Related]
8. Nonbiologic Immune Suppression in Ulcerative Colitis.
Heron V; Loftus EV
Gastroenterol Clin North Am; 2020 Dec; 49(4):731-738. PubMed ID: 33121692
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine and other immunosuppressive agents: current and future role in the treatment of inflammatory bowel disease.
Present DH
Am J Gastroenterol; 1993 May; 88(5):627-30. PubMed ID: 8480721
[No Abstract] [Full Text] [Related]
10. Do immunosuppressants really work as maintenance therapy after the achievement of remission of severe ulcerative colitis?
Naganuma M; Hibi T
J Gastroenterol; 2002; 37(4):315-7. PubMed ID: 11993519
[No Abstract] [Full Text] [Related]
11. Immunosuppressive therapy for ulcerative colitis, ileitis, and granulomatous colitis.
Wisch N; Korelitz BI
Surg Clin North Am; 1972 Aug; 52(4):961-9. PubMed ID: 5047533
[No Abstract] [Full Text] [Related]
12. Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study.
Vos AC; Bakkal N; Minnee RC; Casparie MK; de Jong DJ; Dijkstra G; Stokkers P; van Bodegraven AA; Pierik M; van der Woude CJ; Oldenburg B; Hommes DW;
Inflamm Bowel Dis; 2011 Sep; 17(9):1837-45. PubMed ID: 21830262
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease.
Sultan K; Korelitz BI; Present D; Katz S; Sunday S; Shapira I
Inflamm Bowel Dis; 2012 Oct; 18(10):1855-8. PubMed ID: 22241664
[TBL] [Abstract][Full Text] [Related]
14. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.
Kotlyar DS; Lewis JD; Beaugerie L; Tierney A; Brensinger CM; Gisbert JP; Loftus EV; Peyrin-Biroulet L; Blonski WC; Van Domselaar M; Chaparro M; Sandilya S; Bewtra M; Beigel F; Biancone L; Lichtenstein GR
Clin Gastroenterol Hepatol; 2015 May; 13(5):847-58.e4; quiz e48-50. PubMed ID: 24879926
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous lymphoma in a patient with ulcerative colitis after immunosuppressive therapy.
Rojas-Feria M; Eslam M; Castro-Fernández M; Guerrero P; Larraona-Moreno JL; Romero-Gómez M
J Crohns Colitis; 2011 Dec; 5(6):608-11. PubMed ID: 22115382
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine and mercaptopurine: lymphoma.
Prescrire Int; 2011 May; 20(116):126. PubMed ID: 21648178
[TBL] [Abstract][Full Text] [Related]
17. Azathioprine-induced hypersensitivity hepatitis: tolerance to 6-mercaptopurine.
Andrejic J; Rojas-Balcazar J; Dennis M; Berkelhammer C
Inflamm Bowel Dis; 2010 Nov; 16(11):1828-9. PubMed ID: 20196148
[No Abstract] [Full Text] [Related]
18. Role and side-effects of TPMT polymorphisms of 6-MP and azathioprine in the treatment of steroid-resistant and -dependent ulcerative colitis.
Asakura H
J Gastroenterol; 2003; 38(8):806-9. PubMed ID: 14505139
[No Abstract] [Full Text] [Related]
19. Lack of Increased Risk of Lymphoma with Thiopurine Therapy Regardless of Dose and Duration of Treatment in Japanese Patients with Inflammatory Bowel Diseases.
Kobayashi T; Udagawa E; Hibi T
Digestion; 2022; 103(2):169-173. PubMed ID: 34983046
[TBL] [Abstract][Full Text] [Related]
20. Dosing azathioprine in thiopurine S-methyltransferase deficient inflammatory bowel disease patients.
Derijks LJ; van Helden RB; Hommes DW; Stokkers PC
Gut; 2008 Jun; 57(6):872. PubMed ID: 18477684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
